Rounds / Sereido Therapeutics
ST
Sereido Therapeutics raises ¥400M (Series B 2nd Close)
- Company
- Sereido Therapeutics
- Reported
- 5 Oct 2026 · that week's brief
- Stage
- Series B 2nd Close · 「シリーズBラウンド 2nd Close」 ·
- Amount
- ¥400M1 · as announced: 「総額4億円」
- Breakdown
- Equity ¥400M
- Status
- Not yet registry-confirmed
- Notes
- Found via STARTUP LOG; checked against the company release. Instrument as stated: 第三者割当増資.
- Investors
- Shionogi & Co.Teikoku Ventures, Inc. · list incomplete (release ends with 等/ほか)
- Sector
- BiotechDeep tech
- Source
- Release (PR TIMES; no announcement found on the company's own site yet) · News coverage
1 ≈ ~$2.5M at the ECB reference rate on 2026-10-05 (¥1 = $0.00631). Yen is the figure of record. Methodology
Get the weekly brief
Every Japanese funding round worth knowing, in one English email. Free. Subscribe on Substack →
Every Japanese funding round worth knowing, in one English email. Free. Subscribe on Substack →